Using E.coli as a microbial host to produce the PEP 2RA3, a newly discovered, stable enzyme which breaks down one of two main protein groups which make up gluten. The bacterial produced enzymes will be formulated into a pill which we hope will act similarly to a lactase pill for people with lactose intolerance, in that it will help affected individuals safely ingest foods containing gluten.